EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Palak Patel, Stephanie Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah Hawley, Lisa F Newcomb, Daniel W Lin, Peter S Nelson, Ziding Feng, Hilary D Boyer, Maria S Tretiakova und 21 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100241 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Modern Pathology, 2023. Verfasst von Palak Patel und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology at The Arthur and Sonia Labatt Brain Tumour Research Centre at the Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Prostatic Neoplasms, Artificial Intelligence, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseProstatic NeoplasmsArtificial IntelligenceBiomarkers, TumorHumansMaleRetrospective StudiesMiddle AgedAgedNeoplasm Recurrence, LocalProstatectomyImmunohistochemistryPredictive Value of Tests

Stichwörter der Autor:innen

artificial intelligencemetastasisprostate cancerquantitative PTEN lossrisk stratification

Substanzen

PTEN PhosphohydrolasePTEN protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Cell Biology at The Arthur and Sonia Labatt Brain Tumour Research Centre at the Hospital for Sick Children, Toronto, Ontario, Canada.
  • Molecular Imaging Branch, National Cancer Institute, Bethesda, Maryland; Artificial Intelligence Resource, National Cancer Institute, Bethesda, Maryland.
  • Division of Cancer Biology and Genetics, Queen's University, Kingston, Ontario, Canada.
  • University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Canary Foundation, Woodside, California.
  • Department of Urology, University of Washington Medical Center, Seattle, Washington.

Förderung

  • NCI NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Patel, P., Harmon, S., Iseman, R., Ludkowski, O., Auman, H., Hawley, S., Newcomb, L. F., Lin, D. W., Nelson, P. S., Feng, Z., Boyer, H. D., Tretiakova, M. S., True, L. D., Vakar-Lopez, F., Carroll, P. R., Cooperberg, M. R., Chan, E., Simko, J., Fazli, L., …, & Jamaspishvili, T. (2023). Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100241

Vancouver

Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, et al. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100241

BibTeX
@article{Patel2023,
  author = {Patel, Palak and Harmon, Stephanie and Iseman, Rachael and Ludkowski, Olga and Auman, Heidi and Hawley, Sarah and Newcomb, Lisa F and Lin, Daniel W and Nelson, Peter S and Feng, Ziding and Boyer, Hilary D and Tretiakova, Maria S and True, Larry D and Vakar-Lopez, Funda and Carroll, Peter R and Cooperberg, Matthew R and Chan, Emily and Simko, Jeff and Fazli, Ladan and Gleave, Martin and Hurtado-Coll, Antonio and Thompson, Ian M and Troyer, Dean and McKenney, Jesse K and Wei, Wei and Choyke, Peter L and Bratslavsky, Gennady and Turkbey, Baris and Siemens, D Robert and Squire, Jeremy and Peng, Yingwei P and Brooks, James D and Jamaspishvili, Tamara},
  title = {Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100241}
}
Kostenlos starten →